Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway.

Abstract

BACKGROUND:

Rheumatoid arthritis (RA) is a chronic autoimmune disease that can cause joint inflammation and damage. Leonurine (LE) is an alkaloid found in Leonurus heterophyllus. It has anti-inflammatory effects.

HYPOTHESIS/PURPOSE:

The molecular mechanisms by which LE acts in RA are unclear and further investigation is required.

METHODS:

Mice with collagen-induced arthritis (CIA), and RA-fibroblast-like synoviocytes (FLSs) isolated from them were used as in vivo and in vitro models of RA, respectively. The therapeutic effects of LE on CIA-induced joint injury were investigated by micro-computed tomography, and staining with hematoxylin and eosin and Safranin-O/Fast Green. Cell Counting Kit-8, a Transwell® chamber, enzyme-linked immunosorbent assays, RT-qPCR, and western blotting were used to investigate the effects of LE on RA-FLS viability, migratory capacity, inflammation, microRNA-21 (miR-21) levels, the Hippo signaling pathway, and the effects and intrinsic mechanisms of related proteins. Dual luciferase was used to investigate the binding of miR-21 to YOD1 deubiquitinase (YOD1) and yes-associated protein (YAP). Immunofluorescence was used to investigate the localization of YAP within the nucleus and cytoplasm.

RESULTS:

Treatment with LE significantly inhibited joint swelling, bone damage, synovial inflammation, and proteoglycan loss in the CIA mice. It also reduced the proliferation, cell colonization, migration/invasion, and inflammation levels of RA-FLSs, and promoted miR-21 expression in vitro. The effects of LE on RA-FLSs were enhanced by an miR-21 mimic and reversed by an miR-21 inhibitor. The dual luciferase investigation confirmed that both YOD1 and YAP are direct targets of miR-21. Treatment with LE activated the Hippo signaling pathway, and promoted the downregulation and dephosphorylation of MST1 and LATS1 in RA, while inhibiting the activation of YOD1 and YAP. Regulation of the therapeutic effects of LE by miR-21 was counteracted by YOD1 overexpression, which caused the phosphorylation of YAP and prevented its nuclear ectopic position, thereby reducing LE effect on pro-proliferation-inhibiting apoptosis target genes.

CONCLUSION:

LE regulates the Hippo signaling pathway through the miR-21/YOD1/YAP axis to reduce joint inflammation and bone destruction in CIA mice, thereby inhibiting the growth and inflammation of RA-FLSs. LE has potential for the treatment of RA.

• Authors: Xiao-Na Ma, Wei Feng, Nan Li, Shu-Lin Chen, Xiao-Qin Zhong, Jia-Xu Chen, Chang-Song Lin, Qiang Xu
• Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 123 Pg. 155243 (Jan 2024) ISSN: 1618-095X [Electronic] Germany
• PMID: 38056147 (Publication Type: Journal Article)
• Copyright: Copyright © 2023 Elsevier GmbH. All rights reserved.

Chemical References

• leonurine
• MicroRNAs
• Luciferases
• Gallic Acid

Topics

• Animals
• Mice
• Hippo Signaling Pathway
• X-Ray Microtomography
• Arthritis, Rheumatoid (metabolism)
• Arthritis, Experimental (chemically induced)
• MicroRNAs (genetics)
• Inflammation (metabolism)
• Luciferases (metabolism, pharmacology, therapeutic use)
• Cell Proliferation
• Fibroblasts
• Cells, Cultured
• Gallic Acid (analogs & derivatives)